393 related articles for article (PubMed ID: 9668168)
1. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
[TBL] [Abstract][Full Text] [Related]
2. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
[TBL] [Abstract][Full Text] [Related]
3. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
Griesser J; Kaufmann D; Eisenbarth I; Bäuerle C; Krone W
Biol Chem Hoppe Seyler; 1995 Feb; 376(2):91-101. PubMed ID: 7794530
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the GAP-related domain from neurofibromin and its implications.
Scheffzek K; Ahmadian MR; Wiesmüller L; Kabsch W; Stege P; Schmitz F; Wittinghofer A
EMBO J; 1998 Aug; 17(15):4313-27. PubMed ID: 9687500
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
[TBL] [Abstract][Full Text] [Related]
6. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.
Führer S; Tollinger M; Dunzendorfer-Matt T
J Mol Biol; 2019 Sep; 431(19):3889-3899. PubMed ID: 31401120
[TBL] [Abstract][Full Text] [Related]
8. [Genetics of type 1 neurofibromatosis].
Garavelli L; Donadio A; Sigorini M; Grassi L; Banchini G
Acta Biomed Ateneo Parmense; 2000; 71(3-4):89-95. PubMed ID: 11424621
[TBL] [Abstract][Full Text] [Related]
9. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
Martin GA; Viskochil D; Bollag G; McCabe PC; Crosier WJ; Haubruck H; Conroy L; Clark R; O'Connell P; Cawthon RM
Cell; 1990 Nov; 63(4):843-9. PubMed ID: 2121370
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue JE; Cohen BD; Lowy DR
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
[TBL] [Abstract][Full Text] [Related]
11. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
Upadhyaya M; Osborn MJ; Maynard J; Kim MR; Tamanoi F; Cooper DN
Hum Genet; 1997 Jan; 99(1):88-92. PubMed ID: 9003501
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
Abramowicz A; Gos M
Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
[TBL] [Abstract][Full Text] [Related]
14. Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.
Brems H; Legius E
Keio J Med; 2013; 62(4):107-12. PubMed ID: 24334617
[TBL] [Abstract][Full Text] [Related]
15. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of neurofibromin in the soft tissue tumours obtained from patients with neurofibromatosis type I.
Takahashi K; Suzuki H; Hatori M; Abe Y; Kokubun S; Sakurai M; Shibahara S
Clin Sci (Lond); 1995 May; 88(5):581-5. PubMed ID: 7614817
[TBL] [Abstract][Full Text] [Related]
17. A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex.
Arun V; Wiley JC; Kaur H; Kaplan DR; Guha A
J Neurosci Res; 2013 Apr; 91(4):494-505. PubMed ID: 23361976
[TBL] [Abstract][Full Text] [Related]
18. The guanine triphosphatase (GTPase) activating protein (GAP)-related domain of the neurofibromatosis type 1 gene is not mutated in neural crest-derived sporadic tumours.
Murgia A; Anglani F; Vinanzi C; Polli R; Basso G; Perilongo G; Giangaspero F; Zacchello F
Eur J Cancer; 1998 Mar; 34(4):577-9. PubMed ID: 9713312
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
[TBL] [Abstract][Full Text] [Related]
20. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
